Showing 5,901 - 5,920 results of 29,338 for search '(( 50 ((nn decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( a web decrease ))', query time: 0.63s Refine Results
  1. 5901

    Identification of +TIPs required for MT plus-end targeting of dynein-dynactin in the <i>C</i>. <i>elegans</i> early embryo. by Daniel J. Barbosa (4288462)

    Published 2017
    “…<b>(C)</b> Cortical confocal section in one-cell embryos co-expressing GFP::p50<sup>DNC-2</sup> and EBP-2::mKate2, showing that depletion of dynein intermediate chain<sup>DYCI-1</sup> or LIS-1 decreases dynactin levels at MT plus ends. …”
  2. 5902

    The Strong <i>In Vivo</i> Anti-Tumor Effect of the UIC2 Monoclonal Antibody Is the Combined Result of Pgp Inhibition and Antibody Dependent Cell-Mediated Cytotoxicity by Gábor Szalóki (631712)

    Published 2014
    “…However, this inhibition is partial, since UIC2 binds only to 10–40% of cell surface Pgps, while the rest becomes accessible to this antibody only in the presence of certain substrates or modulators (e.g. cyclosporine A (CsA)). The combined addition of UIC2 and 10 times lower concentrations of CsA than what is necessary for Pgp inhibition when the modulator is applied alone, decreased the EC<sub>50</sub> of doxorubicin (DOX) in KB-V1 (Pgp<sup>+</sup>) cells <i>in vitro</i> almost to the level of KB-3-1 (Pgp<sup>-</sup>) cells. …”
  3. 5903
  4. 5904

    GRADE judgements. by Da Huang (1306407)

    Published 2025
    “…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
  5. 5905

    The data of meta-analysis. by Da Huang (1306407)

    Published 2025
    “…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
  6. 5906

    Risk of bias. by Da Huang (1306407)

    Published 2025
    “…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
  7. 5907

    Overall risk of bias assessment. by Da Huang (1306407)

    Published 2025
    “…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
  8. 5908

    Funnel plot of VO<sub>2Peak</sub> inclusion studies. by Da Huang (1306407)

    Published 2025
    “…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
  9. 5909

    Analysis of subgroups. by Da Huang (1306407)

    Published 2025
    “…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
  10. 5910

    Screening for cell culture grown HCV genotype 1a (clone H77) infectivity in the presence of vaccine sera. by Keith Meyer (309742)

    Published 2013
    “…Neutralizing sera are those which display ≥50% decrease in FFU at a dilution of ≥1∶20 (panel A). …”
  11. 5911

    Disorder–Order Structural Transformation in Electron-Poor Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> Driven by Chemical Bonding Optimization by Qisheng Lin (1680814)

    Published 2013
    “…Single-crystal X-ray diffraction analyses revealed that Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> has a La<sub>3</sub>Al<sub>11</sub>-type <i>Immm</i> structure (<i>a</i> = 4.6767(8) Å, <i>b</i> = 9.646(2) Å, <i>c</i> = 14.170(2) Å, <i>Z</i> = 2) if annealed at 550 °C and above but a Ca<sub>3</sub>Au<sub>8</sub>Ge<sub>3</sub>-type structure (<i>Pnnm</i>, <i>a</i> = 9.6082(8) Å, <i>b</i> = 14.171(1) Å, <i>c</i> = 4.6719(4) Å, <i>Z</i> = 2) if annealed at 400 °C. …”
  12. 5912
  13. 5913

    Engineering of p150<sup>DNC-1</sup> mutants for functional characterization of dynactin's MT binding activity. by Daniel J. Barbosa (4288462)

    Published 2017
    “…<p><b>(A)</b> Cartoon of the dynactin complex and its interaction with MTs and end-binding protein (EB). …”
  14. 5914

    Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment? by Graciane Radaelli (5186603)

    Published 2018
    “…Objective: Systematic review of randomized clinical trials of statin use to treat children and adolescents with dyslipidemia secondary to obesity. Methods: We performed a search in PubMed, EMBASE, Bireme, Web of Science, Cochrane Library, SciELO, and LILACS for data to evaluate the effect of statins on: improvement of surrogate markers of coronary artery disease in clinical outcomes of adulthood; increased serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipropotein B (APOB); and decreased serum levels of high-density lipoprotein cholesterol (HDL-C) from inception to February 2016. …”
  15. 5915

    Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment? by Graciane Radaelli (5186603)

    Published 2018
    “…Objective: Systematic review of randomized clinical trials of statin use to treat children and adolescents with dyslipidemia secondary to obesity. Methods: We performed a search in PubMed, EMBASE, Bireme, Web of Science, Cochrane Library, SciELO, and LILACS for data to evaluate the effect of statins on: improvement of surrogate markers of coronary artery disease in clinical outcomes of adulthood; increased serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipropotein B (APOB); and decreased serum levels of high-density lipoprotein cholesterol (HDL-C) from inception to February 2016. …”
  16. 5916
  17. 5917

    Image_1_Eph-ephrin Signaling Affects Eye Lens Fiber Cell Intracellular Voltage and Membrane Conductance.TIF by Catherine Cheng (114496)

    Published 2021
    “…Immunostaining revealed changes in connexin 50 (Cx50) subcellular localization in EphA2<sup>–/–</sup> peripheral lens fibers and alteration in aquaporin 0 (Aqp0) staining patterns in ephrin-A5<sup>–/–</sup> and EphA2<sup>–/–</sup> inner mature fiber cells. …”
  18. 5918
  19. 5919

    Morphological schematic diagram of <i>A</i>. <i>Adenophora</i>. by Haojun Li (11007721)

    Published 2024
    “…The phytochemical variability of the extracts was also studied. The LC<sub>50</sub> value of the <i>A</i>. <i>adenophora</i> extract against <i>L</i>. …”
  20. 5920